HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Begoña Santiago Selected Research

C-Reactive Protein

12/2022Performance of QuantiFERON-TB Gold Plus assays in children and adolescents at risk of tuberculosis: a cross-sectional multicentre study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Begoña Santiago Research Topics

Disease

9Rheumatoid Arthritis
02/2012 - 02/2003
7Tuberculosis (Tuberculoses)
12/2022 - 07/2012
2Hypoxia (Hypoxemia)
02/2011 - 10/2009
2Inflammation (Inflammations)
01/2006 - 02/2003
1Lymphopenia (Lymphocytopenia)
12/2022
1Lymph Node Tuberculosis (Scrofula)
09/2021
1Lymphadenitis (Adenitis)
09/2021
1Chemical and Drug Induced Liver Injury
01/2019
1Liver Diseases (Liver Disease)
01/2019
1Infections
03/2015
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
04/2014
1Hepatitis
07/2012
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2012
1Nephritis
05/2012
1Rubella (German Measles)
02/2012
1Starvation
02/2011
1Iron Overload
06/2010
1Hemochromatosis (Bronze Diabetes)
06/2010
1Lupus Nephritis
08/2009
1Arthritis (Polyarthritis)
04/2008
1Experimental Arthritis
03/2008
1Necrosis
06/2007
1Psoriatic Arthritis
06/2007
1Osteoarthritis
01/2006
1Disease Susceptibility (Diathesis)
10/2005
1Cicatrix (Scar)
09/2005
1Fibrosis (Cirrhosis)
09/2005

Drug/Important Bio-Agent (IBA)

4ChemokinesIBA
06/2007 - 02/2003
3GoldIBA
12/2022 - 01/2020
2Isoniazid (Ftivazide)FDA LinkGeneric
04/2014 - 07/2012
2AntibodiesIBA
02/2012 - 08/2009
2Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
04/2008 - 03/2008
2Peptides (Polypeptides)IBA
03/2008 - 09/2005
2Chemokine CXCL12IBA
01/2005 - 02/2003
1C-Reactive ProteinIBA
12/2022
1Interferon-gamma (Interferon, gamma)IBA
09/2021
1Pharmaceutical PreparationsIBA
01/2019
1Linezolid (Zyvox)FDA Link
01/2019
1Anti-Bacterial Agents (Antibiotics)IBA
03/2015
1Tuberculin (PPD)IBA
03/2015
1Rifampin (Rifampicin)FDA LinkGeneric
07/2012
1Complement System Proteins (Complement)IBA
05/2012
1Protein Isoforms (Isoforms)IBA
02/2012
1Messenger RNA (mRNA)IBA
02/2011
1Proteins (Proteins, Gene)FDA Link
02/2011
1CytokinesIBA
02/2011
1IronIBA
06/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2009
1Transcription Factors (Transcription Factor)IBA
10/2009
1Small Interfering RNA (siRNA)IBA
10/2009
1Phospholipids (Phosphatides)FDA LinkGeneric
08/2009
1AutoantibodiesIBA
06/2007
1L-selectin counter-receptorsIBA
06/2007
1enhanced green fluorescent proteinIBA
10/2006
1Death Domain ReceptorsIBA
05/2006
1LigandsIBA
05/2006
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
01/2006
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
10/2005
1CollagenIBA
09/2005
1Transforming Growth Factor beta (TGF-beta)IBA
09/2005
1Bleomycin (Blenoxane)FDA LinkGeneric
09/2005
1Transforming Growth Factor beta1 (TGF beta 1)IBA
09/2005
1Lymphotoxin-alpha (Lymphotoxin)IBA
03/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2005
1SulfotransferasesIBA
03/2005
1EpitopesIBA
03/2005
1Heparitin Sulfate (Heparan Sulfate)IBA
02/2003

Therapy/Procedure

1Hematopoietic Stem Cell Transplantation
07/2012
1Therapeutics
09/2005